Cambridge Innovation Capital
AI Verified
Location
Investor type
Current investment status
Website
Linkedin
Company address
Founding year
Twitter
Facebook
United Kingdom
Investor type
Venture Capital
Current investment status
00 00 00
Website
00 00 00
Company address
Twenty-Two Station Road, 22, Station Road, Petersfield, Cambridge, Cambridgeshire, Cambridgeshire and Peterborough, England, CB1 2JD, United Kingdom
Founding year
2013
00 00 00
00 00 00
| Criteria | Requirements | Match |
|---|---|---|
| Regions |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Impact Area |
00 00 00
|
|
| Stage |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Min. - Max. ticket size |
00 00 00
-
00 00 00
USD
|
00
|
| Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
| Min. revenue |
00 00 00
USD
|
00
|
| Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company Description
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe's leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. CIC currently manages over £500 million and has invested in 30+ companies. We invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Highlights
€500 Million assets under management
Focus on deeptech and life sciences
Founded by Hermann Hauser and Ian Lane
Preferred investor for the University of Cambridge
Investing in disruptive, deep-tech businesses
Ready to raise better?
Start your free trial!